UK study reveals how prostate cancer evades treatment
The cover of Science Signaling Vol. 18, Issue 878 LEXINGTON, Ky. — A team of University of Kentucky Markey Cancer Center researchers have found the mechanism that grants prostate cancer resistance to enzalutamide, a frequently used drug treatment. The …